ICLR Stock Analysis: Buy, Sell, or Hold?
ICLR - Icon Plc
$163.57
-1.97 (-1.19%)
▼
5d:
-1.32%
30d:
-6.56%
90d:
+38.23%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When ICLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ICLR shows positive signals but monitor for confirmation. Market pricing in 6.5% growth. Moderate conviction.
💡 BUY OPPORTUNITY: ICLR shows positive signals but monitor for confirmation. Market pricing in 6.5% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$197.14
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$122.41
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICLR is currently trading at $163.56, which is considered fair relative to its 30-day fair value range of $158.88 to $175.68. From a valuation perspective, the stock is trading at a premium (Forward PE: 13.8) compared to its historical average (11.4). At these levels, the market is pricing in 6.5% annual earnings growth.
Technical Outlook: Technically, ICLR is in a strong uptrend. The price is currently testing key support at $161.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $182.81 (+11.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ICLR is in a strong uptrend. The price is currently testing key support at $161.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $182.81 (+11.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$158.88 -
$175.68
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.3%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($182.81)
- BULLISH: Expecting earnings turnaround to 6.5% growth with 0.9% revenue growth
Trading Range Analysis
30-Day Trading Range
$158.88 -
$175.68
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$161.29
Resistance Level
$186.64
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.78
Wall Street Target
$182.81
(+11.8%)
Revenue Growth (YoY)
0.9%
Earnings Growth (YoY)
-31.7%
Profit Margin
2.1%
Valuation Premium vs History
+6.5% premium
PE vs Historical
13.8 vs 11.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.5%
(market-implied from PE analysis)
1-Year Target
$174.20
(+7%)
2-Year Target
$185.52
(+13%)
3-Year Target
$197.58
(+21%)
3-Yr Target (if PE normalizes)
(PE: 14→11)
PE COMPRESSION
$163.46
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 11.7%)
$343.21
(+110%)
Base:
(SPY PE: 13.8, Growth: 11.7%)
$228.14
(+40%)
Bear:
(PE: 11.4, Growth: 11.7%)
$188.74
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Forward PE: 17.06 | Forward EPS (Implied): $9.58
Bull Case
$197.50
(+21%)
Analyst growth 15.0%, PE expands to 17.9
Base Case
$163.56
(0%)
Market implied 0.0%, PE stable at 17.1
Bear Case
$125.13
(-24%)
Severe decline -15.0%, PE contracts to 15.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 03, 2026 2:15 AM ET
Data refreshes hourly during market hours. Next update: 3:15 AM
Data refreshes hourly during market hours. Next update: 3:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
Advanced ICLR Option Strategies
Professional options setups generated by AI based on today's ICLR price and gamma walls.
